Silverberg, J.I., Kragh, N., Guttman-Yassky, E. and Wollenberg, A. 2018. Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S64. DOI:https://doi.org/10.25251/skin.2.supp.64.